These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 27821628)

  • 1. Gene-Specific DNA Methylation Changes Predict Remission in Patients with ANCA-Associated Vasculitis.
    Jones BE; Yang J; Muthigi A; Hogan SL; Hu Y; Starmer J; Henderson CD; Poulton CJ; Brant EJ; Pendergraft WF; Jennette JC; Falk RJ; Ciavatta DJ
    J Am Soc Nephrol; 2017 Apr; 28(4):1175-1187. PubMed ID: 27821628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone modification signature at myeloperoxidase and proteinase 3 in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis.
    Yang J; Ge H; Poulton CJ; Hogan SL; Hu Y; Jones BE; Henderson CD; McInnis EA; Pendergraft WF; Jennette JC; Falk RJ; Ciavatta DJ
    Clin Epigenetics; 2016; 8():85. PubMed ID: 27752292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic basis for aberrant upregulation of autoantigen genes in humans with ANCA vasculitis.
    Ciavatta DJ; Yang J; Preston GA; Badhwar AK; Xiao H; Hewins P; Nester CM; Pendergraft WF; Magnuson TR; Jennette JC; Falk RJ
    J Clin Invest; 2010 Sep; 120(9):3209-19. PubMed ID: 20714105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysregulation of autoantigen genes in ANCA-associated vasculitis involves alternative transcripts and new protein synthesis.
    McInnis EA; Badhwar AK; Muthigi A; Lardinois OM; Allred SC; Yang J; Free ME; Jennette JC; Preston GA; Falk RJ; Ciavatta DJ
    J Am Soc Nephrol; 2015 Feb; 26(2):390-9. PubMed ID: 25060059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ANCA autoantigen gene expression highlights neutrophil heterogeneity where expression in normal-density neutrophils correlates with ANCA-induced activation.
    Jones BE; Herrera CA; Agosto-Burgos C; Starmer J; Bass WA; Poulton CJ; Blazek L; Henderson CD; Hu Y; Hogan SL; Hu P; Xiao H; Wu EY; Chen DP; Jennette JC; Free ME; Falk RJ; Ciavatta DJ
    Kidney Int; 2020 Sep; 98(3):744-757. PubMed ID: 32446935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PRTN3 variant correlates with increased autoantigen levels and relapse risk in PR3-ANCA versus MPO-ANCA disease.
    Chen DP; Aiello CP; McCoy D; Stamey T; Yang J; Hogan SL; Hu Y; Derebail VK; Wu EY; Jennette JC; Falk RJ; Ciavatta DJ
    JCI Insight; 2023 Feb; 8(4):. PubMed ID: 36626226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent pathogenetic advances in ANCA-associated vasculitis.
    Pendergraft WF; Nachman PH
    Presse Med; 2015 Jun; 44(6 Pt 2):e223-9. PubMed ID: 26033562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological Interaction of HLA-DPB1 and Proteinase 3 in ANCA Vasculitis is Associated with Clinical Disease Activity.
    Chen DP; McInnis EA; Wu EY; Stember KG; Hogan SL; Hu Y; Henderson CD; Blazek LN; Mallal S; Karosiene E; Peters B; Sidney J; James EA; Kwok WW; Jennette JC; Ciavatta DJ; Falk RJ; Free ME
    J Am Soc Nephrol; 2022 Aug; 33(8):1517-1527. PubMed ID: 35672132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of relapse of ANCA-associated vasculitis among patients homozygous for the proteinase 3 gene Val119Ile polymorphism.
    Casal Moura M; Deng Z; Brooks SR; Tew W; Fervenza FC; Kallenberg CGM; Langford CA; Merkel PA; Monach PA; Seo P; Spiera RF; St Clair EW; Stone JH; Prunotto M; Grayson PC; Specks U
    RMD Open; 2023 Mar; 9(1):. PubMed ID: 36990659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended versus standard azathioprine maintenance therapy in newly diagnosed proteinase-3 anti-neutrophil cytoplasmic antibody-associated vasculitis patients who remain cytoplasmic anti-neutrophil cytoplasmic antibody-positive after induction of remission: a randomized clinical trial.
    Sanders JS; de Joode AA; DeSevaux RG; Broekroelofs J; Voskuyl AE; van Paassen P; Kallenberg CG; Tervaert JW; Stegeman CA
    Nephrol Dial Transplant; 2016 Sep; 31(9):1453-9. PubMed ID: 27242368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Difference in relapse-rate and clinical phenotype by autoantibody-subtype in Japanese patients with anti-neutrophil cytoplasmic antibody-associated vasculitis.
    Murosaki T; Sato T; Akiyama Y; Nagatani K; Minota S
    Mod Rheumatol; 2017 Jan; 27(1):95-101. PubMed ID: 27320904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetics and complementary proteins.
    Ciavatta D; Falk RJ
    Clin Exp Immunol; 2011 May; 164 Suppl 1(Suppl 1):17-9. PubMed ID: 21447125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of vascular damage in ANCA vasculitis.
    Massicotte-Azarniouch D; Herrera CA; Jennette JC; Falk RJ; Free ME
    Semin Immunopathol; 2022 May; 44(3):325-345. PubMed ID: 35254509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A myelopoiesis gene signature during remission in anti-neutrophil cytoplasm antibody-associated vasculitis does not predict relapses but seems to reflect ongoing prednisolone therapy.
    Kurz T; Weiner M; Skoglund C; Basnet S; Eriksson P; Segelmark M
    Clin Exp Immunol; 2014 Feb; 175(2):215-26. PubMed ID: 24215168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and prognostic features of Korean patients with MPO-ANCA, PR3-ANCA and ANCA-negative vasculitis.
    Yoo J; Kim HJ; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
    Clin Exp Rheumatol; 2017; 35 Suppl 103(1):111-118. PubMed ID: 28339364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Functional and Expression Polymorphisms Associated With Risk for Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis.
    Merkel PA; Xie G; Monach PA; Ji X; Ciavatta DJ; Byun J; Pinder BD; Zhao A; Zhang J; Tadesse Y; Qian D; Weirauch M; Nair R; Tsoi A; Pagnoux C; Carette S; Chung S; Cuthbertson D; Davis JC; Dellaripa PF; Forbess L; Gewurz-Singer O; Hoffman GS; Khalidi N; Koening C; Langford CA; Mahr AD; McAlear C; Moreland L; Seo EP; Specks U; Spiera RF; Sreih A; St Clair EW; Stone JH; Ytterberg SR; Elder JT; Qu J; Ochi T; Hirano N; Edberg JC; Falk RJ; Amos CI; Siminovitch KA;
    Arthritis Rheumatol; 2017 May; 69(5):1054-1066. PubMed ID: 28029757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil priming and apoptosis in anti-neutrophil cytoplasmic autoantibody-associated vasculitis.
    Harper L; Cockwell P; Adu D; Savage CO
    Kidney Int; 2001 May; 59(5):1729-38. PubMed ID: 11318943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lessons from a double-transgenic neutrophil approach to induce antiproteinase 3 antibody-mediated vasculitis in mice.
    Schreiber A; Eulenberg-Gustavus C; Bergmann A; Jerke U; Kettritz R
    J Leukoc Biol; 2016 Dec; 100(6):1443-1452. PubMed ID: 27365530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serial ANCA titers: useful tool for prevention of relapses in ANCA-associated vasculitis.
    Han WK; Choi HK; Roth RM; McCluskey RT; Niles JL
    Kidney Int; 2003 Mar; 63(3):1079-85. PubMed ID: 12631091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical presentation and outcome prediction of clinical, serological, and histopathological classification schemes in ANCA-associated vasculitis with renal involvement.
    Córdova-Sánchez BM; Mejía-Vilet JM; Morales-Buenrostro LE; Loyola-Rodríguez G; Uribe-Uribe NO; Correa-Rotter R
    Clin Rheumatol; 2016 Jul; 35(7):1805-16. PubMed ID: 26852317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.